ResearcherUniversity of California, Los AngelesNo recent work listed

Matthias Benz

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-7577-9691; OpenAlex author ID A5068775949. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 6

Papers, trials and grants by year

2022: 1 paper

Papers 1

18F-FDG PET/CT Imaging Biomarkers for Early and Late Evaluation of Response to First-Line Chemotherapy in Patients with Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.2967/jnumed.121.261952 ↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Timothy R. Donahue · 1 shared paper, 2022 · strength 0.14
- Paper 18F-FDG PET/CT Imaging Biomarkers for Early and Late Evaluation of Response to First-Line Chemotherapy in Patients with… DOI 10.2967/jnumed.121.261952 ↗
Zev A. Wainberg · 1 shared paper, 2022 · strength 0.14
- Paper 18F-FDG PET/CT Imaging Biomarkers for Early and Late Evaluation of Response to First-Line Chemotherapy in Patients with… DOI 10.2967/jnumed.121.261952 ↗
Johannes Czernin · 1 shared paper, 2022 · strength 0.14
- Paper 18F-FDG PET/CT Imaging Biomarkers for Early and Late Evaluation of Response to First-Line Chemotherapy in Patients with… DOI 10.2967/jnumed.121.261952 ↗
Mark D. Girgis MD · 1 shared paper, 2022 · strength 0.14
- Paper 18F-FDG PET/CT Imaging Biomarkers for Early and Late Evaluation of Response to First-Line Chemotherapy in Patients with… DOI 10.2967/jnumed.121.261952 ↗
Jérémie Calais · 1 shared paper, 2022 · strength 0.14
- Paper 18F-FDG PET/CT Imaging Biomarkers for Early and Late Evaluation of Response to First-Line Chemotherapy in Patients with… DOI 10.2967/jnumed.121.261952 ↗
Ken Herrmann · 1 shared paper, 2022 · strength 0.14
- Paper 18F-FDG PET/CT Imaging Biomarkers for Early and Late Evaluation of Response to First-Line Chemotherapy in Patients with… DOI 10.2967/jnumed.121.261952 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.